NYSE:VTR
Ventas Inc Stock News
$47.55
+0.110 (+0.232%)
At Close: May 09, 2024
Ventas' (VTR) Outlook Raised by S&P Global, Rating Maintained
12:48pm, Thursday, 19'th May 2022
S&P Global Ratings upgrades Ventas' (VTR) outlook to stable from negative, highlighting improving fundamentals driven by senior housing recovery. Moreover, it maintains the rating at BBB+.
Ventas, Inc. (VTR) CEO Debra Cafaro on Q1 2022 Results - Earnings Call Transcript
03:12pm, Friday, 06'th May 2022
Ventas, Inc. (NYSE:VTR ) Q1 2022 Earnings Conference Call May 6, 2022 10:00 AM ET Company Participants Sarah Whitford - Investor Relations Debra Cafaro - Chairman and Chief Executive Officer Sarah Whi
Ventas' (VTR) FFO Beats Estimates in Q1, SHOP Occupancy Rises
10:32am, Friday, 06'th May 2022
Ventas' (VTR) Q1 results display improvement in FFO aided by increased occupancy in Senior Housing Operating Portfolio segment.
Ventas (VTR) to Report Q1 Earnings: What's in the Offing?
02:17pm, Wednesday, 04'th May 2022
While strength in its Medical Office Building and growing Life Science and Research & Innovation businesses is likely to have aided Ventas (VTR) in Q1, elevated costs might have been a deterrent.
Why I'll Never Sell Ventas
07:17am, Sunday, 24'th Apr 2022
Ventas cut its dividend in 2020, which was bad, but I'm not going to sell it because the REIT has too many positive qualities.
Ventas Announces First Quarter 2022 Earnings Release Date and Conference Call
05:00pm, Thursday, 21'st Apr 2022
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) will issue its first quarter 2022 earnings release after the close of trading on the New York Stock Exchange on T
Proxy advisory firms urge Ventas investors to reject activist's bid for board seat
07:48pm, Wednesday, 20'th Apr 2022
Proxy advisory firms Glass Lewis and Institutional Shareholders Services urged investors in healthcare real estate trust Ventas Inc to back management's director candidates and reject activist investm
Our 3 Worst Performing Investments
08:15am, Monday, 11'th Apr 2022
Our 3 Worst Performing Investments
This Healthcare Real Estate Stock Is Benefiting From Robust Performance in Canada
08:45am, Thursday, 31'st Mar 2022
Ventas' investment in a Canadian senior-housing business has paid off handsomely during the industry downturn.
Ventas: A REIT Recovery Play With A Rock-Solid 3% Yield
10:07am, Wednesday, 23'rd Mar 2022
Ventas is focused on producing net operating income growth in its core division.
Benzinga''s Top Ratings Upgrades, Downgrades For March 11, 2022
03:28pm, Friday, 11'th Mar 2022 Benzinga
Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ: SBRA ) was changed from Underperform to Neutral. In the fourth quarter, Sabra Health Care REIT showed an EPS of $0.39, compared to $0.42 from the year-ago quarter. The current stock performance of Sabra Health Care REIT shows a 52-week-high of $19.02 and a 52-week-low of $12.31. Moreover, at the end of the last trading period, the closing price was at $13.87. CLSA upgraded the previous rating for Gaotu Techedu Inc (NYSE: GOTU ) from Sell to Underperform. For the fourth quarter, Gaotu Techedu had an EPS of $0.19, compared to year-ago quarter EPS of $0.39. The current stock performance of Gaotu Techedu shows a 52-week-high of $93.33 and a 52-week-low of $1.39. Moreover, at the end of the last trading period, the closing price was at $1.70. B of A Securities upgraded the previous rating for XPO Logistics Inc (NYSE: XPO ) from Neutral to Buy. In the fourth quarter, XPO Logistics showed an EPS of $1.34, compared to $1.19 from the year-ago quarter.
Ventas boosted to Outperform at BMO as rent coverage improves; cuts CareTrust
02:03pm, Friday, 11'th Mar 2022 Seeking Alpha
BMO analyst Juan Sanabria on Friday upgraded health care real estate investment trust Ventas (VTR) due to increased confidence in the senior housing recovery.The analyst is forecasting…
Where Ventas Stands With Analysts
02:17pm, Wednesday, 09'th Mar 2022 Benzinga
Within the last quarter, Ventas (NYSE: VTR ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 1 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Ventas has an average price target of $59.0 with a high of $62.00 and a low of $53.00. Below is a summary of how these 4 analysts rated Ventas over the past … Full story available on Benzinga.com
Land & Buildings nominates Jonathan Litt to Ventas board
06:32pm, Monday, 07'th Mar 2022 Seeking Alpha
Land & Buildings Investment Management confirmed on Monday that it is nominating its founder and chief investment officer, Jonathan Litt, to Ventas''s <> board in an effort to…